HK1005876A1 - 17B-(3-furyl) and 17B-(4-pyridazinyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same - Google Patents

17B-(3-furyl) and 17B-(4-pyridazinyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same

Info

Publication number
HK1005876A1
HK1005876A1 HK98104942A HK98104942A HK1005876A1 HK 1005876 A1 HK1005876 A1 HK 1005876A1 HK 98104942 A HK98104942 A HK 98104942A HK 98104942 A HK98104942 A HK 98104942A HK 1005876 A1 HK1005876 A1 HK 1005876A1
Authority
HK
Hong Kong
Prior art keywords
pyridazinyl
furyl
pharmaceutical compositions
compositions containing
14beta
Prior art date
Application number
HK98104942A
Other languages
English (en)
Inventor
Luisa Quadri
Luigi Bernardi
Giuseppe Bianci
Patrizia Ferrari
Piero Melloni
Loredana Valentino
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1005876A1 publication Critical patent/HK1005876A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0021—Oxiranes at position 14(15)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HK98104942A 1992-08-20 1998-06-05 17B-(3-furyl) and 17B-(4-pyridazinyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same HK1005876A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4227616A DE4227616C2 (de) 1992-08-20 1992-08-20 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen

Publications (1)

Publication Number Publication Date
HK1005876A1 true HK1005876A1 (en) 1999-01-29

Family

ID=6465993

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104942A HK1005876A1 (en) 1992-08-20 1998-06-05 17B-(3-furyl) and 17B-(4-pyridazinyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same

Country Status (12)

Country Link
US (2) US5591734A (fr)
EP (1) EP0583578B1 (fr)
JP (2) JP3357427B2 (fr)
KR (1) KR100276528B1 (fr)
AT (1) ATE152118T1 (fr)
CA (1) CA2103826C (fr)
DE (2) DE4227616C2 (fr)
DK (1) DK0583578T3 (fr)
ES (1) ES2100396T3 (fr)
GR (1) GR3023311T3 (fr)
HK (1) HK1005876A1 (fr)
ZA (1) ZA935865B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060194773A1 (en) * 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
EP2332546A1 (fr) 2001-07-13 2011-06-15 Paratek Pharmaceuticals, Inc. Tetracyclines pour le traitement des accidents cérebrovasculaires
EP1951738B1 (fr) 2005-11-25 2012-01-18 Rostaquo S.p.A. Nouvelles formes crystallines de rostafuroxin
EP2026776A2 (fr) 2006-05-15 2009-02-25 Paratek Pharmaceuticals, Inc. Méthodes de régulation de l'expression de gènes ou de produits géniques à l'aide de composés de tétracycline substituée
PT2160190E (pt) * 2007-06-07 2016-01-27 Sigma Tau Ind Farmaceuti Derivados de 5beta, 14 beta-androstano úteis para o tratamento de doenças causadas por fibroses de órgão
BRPI1012240A2 (pt) * 2009-03-23 2018-06-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. derivados de 5-beta, beta-14-androstana úteis para o tratamento de proteinúria, de glomeruloesclerose e de insuficiência renal
WO2010149666A1 (fr) 2009-06-22 2010-12-29 Medexis S.A. Procédés pour traiter une néoplasie
WO2011029639A2 (fr) 2009-09-08 2011-03-17 Medexis S.A. Composés et procédés pour traitement de la néoplasie
CN102695512B (zh) 2009-10-19 2017-05-10 罗斯塔库奥股份公司 用于药物基因组学治疗心血管病症的方法和系统
CN108152432B (zh) * 2017-12-29 2020-11-20 兆科药业（合肥）有限公司 一种罗他夫辛片高效液相检测方法
US11337988B2 (en) 2018-09-27 2022-05-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of ouabain antagonists to inhibit viral infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621803A5 (fr) * 1974-08-08 1981-02-27 Siphar Sa
HU171166B (hu) * 1975-07-15 1977-11-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh ehpoksi-androstanov
DE2614046C2 (de) * 1976-04-01 1984-08-02 Boehringer Mannheim Gmbh, 6800 Mannheim Neue 17α-Hydroxy-Cardenolid-Glykoside, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
US4380624A (en) * 1981-07-31 1983-04-19 Advance Biofactures Corp. Novel isomers of bufalin and resibufogenin and their preparation
DE4221636C1 (de) * 1992-07-01 1994-03-31 Sigma Tau Ind Farmaceuti Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate

Also Published As

Publication number Publication date
DE69310052T2 (de) 1997-09-18
DE4227616A1 (de) 1994-03-10
US5591734A (en) 1997-01-07
CA2103826A1 (fr) 1994-02-21
EP0583578B1 (fr) 1997-04-23
JPH06157586A (ja) 1994-06-03
CA2103826C (fr) 1998-12-22
DE4227616C2 (de) 1995-04-13
JPH06219951A (ja) 1994-08-09
US5567697A (en) 1996-10-22
EP0583578A2 (fr) 1994-02-23
ZA935865B (en) 1994-03-10
JP3357427B2 (ja) 2002-12-16
DE69310052D1 (de) 1997-05-28
DK0583578T3 (da) 1997-07-21
KR940003964A (ko) 1994-03-14
GR3023311T3 (en) 1997-08-29
KR100276528B1 (ko) 2001-02-01
EP0583578A3 (en) 1994-07-06
ATE152118T1 (de) 1997-05-15
ES2100396T3 (es) 1997-06-16

Similar Documents

Publication Publication Date Title
EP0590271A3 (en) 17-aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
WO1991018866A3 (fr) 1,4-diamino-2,3-dihydroxybutanes
IL67572A (en) Trans-2-aza bicyclo(3.(3+n).o)alkane-3-carboxylic acid derivatives,processes for their preparation and pharmaceutical compositions containing them
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL83467A0 (en) Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same
IL96019A0 (en) Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
DE3374686D1 (en) 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
AU7929391A (en) New 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles and 1,2,3,4-tetrahydro-beta-carbolines processes for preparing these and pharmaceutical compositions containing them
EP0583578A3 (en) 17-(3-furyl) and 17-(4-pyridazinyl)-5beta,14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
CA2153549A1 (fr) Nouveau derive de benzothiadiazine, son procede de preparation et les compositions pharmeceutiques qui le contiennent
IL87563A (en) Isoxazole-b-carboline derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUT45249A (en) Process for producing 6,7,8,9-tetrahydro-10-methylpyrido/1,2-a/indol-9-amines, theyr derivatives and pharmaceutical compositions containing them as active components
GR3031118T3 (en) Novel seco-D steroids active in the cardiovascular system and pharmaceutical compositions containing same
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
HUT47096A (en) Process for producing 1,2-dithiol-3-thion derivatives and pharmaceutical compositions containing them as active components
ZA87332B (en) Compositions containing fixed combinations
AU8917891A (en) Poly-aminopyrrolecarboxamido derivatives, processes for their preparation and pharmaceutical compositions containing them
CA2103825A1 (fr) Derives de 17-hydroxyiminomethyl-5.beta.,14.beta.-androstane actifs sur le systeme_cardiovasculaire, procedes pour leur preparation et compositions pharmaceutiques en contenant
AU617929B2 (en) Novel steroid derivatives, pharmaceutical compositions containing them and process for preparing same
EP0226842A3 (fr) 1,4-Naphtalènediones substitués, procédés pour leur préparation et compositions pharmaceutiques les contenant
EP0590272A3 (en) 17-aryl and 17-heterocyclyl-5-beta, 14-beta-andostane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
EP0386920A3 (fr) Dérivés d'hydroxy-2-thiénylox-3-propylamine
IL82294A0 (en) 1,3-dihydropyridine derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
AU8972591A (en) Novel 15-nitro-2beta,3beta-dihydro- and 15-nitro-2beta,3beta,6,7-tetrahydrotabersonine derivatives, pharmaceutical compositions containing them and process for preparing same

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20130624